International IMP Services, a specialized company within Pierrel Research group, is proud to provide high quality Investigational Medicinal Product (IMP) services for international clinical trials.
Services include contract IMP manufacture (packaging, labeling, certification by QP in accordance with Directive 2001/20/EC) and IMP logistics tailored to meet the specific requirements of phase I through phase IV clinical trials.
We are a leading global provider of clinical trial services combining more than 20 years of experience in the planning and conduct of GCP-compliant clinical trials with thorough knowledge of legal, GMP, and practical requirements for IMP manufacture and logistics.
Our clients benefit by receiving expert clinical trial management and IMP services all from one convenient source.
We take into account the products and procedures unique to each study. Then, we employ our scientific, regulatory, operational, and commercial resources to structure customized and integrated solutions to manufacture your IMP. In this way, we help our clients shorten timelines, reduce costs, and optimize IMP concepts for packaging, labeling and logistic strategies and solutions.
International IMP Services are located at Cantù (Italy). The production plant is EMA approved and it is equipped for manufacturing, stability analysis, packaging, labeling, batch release and certification.
We minimize time and costs from idea to IMP availability.